trilliondollar

Long KMPH below $10

看多
NASDAQ:KMPH   None
FDA approval with potential short squeeze. Without these catalyst the market cap still suggests that it is undervalued with the new addressable market of KP415/AZSTARYS
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。